The Evolving Biomarkers in Cervical Cancer: Integrating Multi-Omic and Emerging Approaches for Precision Cervical Cancer Diagnostics
Cervical cancer remains a major global health burden despite being one of the most preventable malignancies. The transition from conventional morphology-based screening to human papillomavirus (HPV)-based testing has improved detection sensitivity; however, HPV positivity alone cannot reliably distinguish transient inf...